Key Details
Price
$0.66Annual Revenue
$32.31 MAnnual EPS
-$25.50Annual ROE
-14.34%Beta
1.25Events Calendar
Next earnings date:
Jan 30, 2025Recent quarterly earnings:
Sept 20, 2024Recent annual earnings:
Jan 30, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 18, 2024Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
New York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) of its client Universe Pharmaceuticals INC (NASDAQ: UPC) (the “Company”), a pharmaceutical producer and distributor in China.
JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024.
Universe Pharmaceuticals (NASDAQ: UPC ) stock is falling on Tuesday after the company's shares experienced a rally during the prior day of trading. Shares of UPC closed out Friday up 43.9% without any clear news from the traditional Chinese medicine company.
FAQ
- What is the primary business of Universe Pharmaceuticals?
- What is the ticker symbol for Universe Pharmaceuticals?
- Does Universe Pharmaceuticals pay dividends?
- What sector is Universe Pharmaceuticals in?
- What industry is Universe Pharmaceuticals in?
- What country is Universe Pharmaceuticals based in?
- When did Universe Pharmaceuticals go public?
- Is Universe Pharmaceuticals in the S&P 500?
- Is Universe Pharmaceuticals in the NASDAQ 100?
- Is Universe Pharmaceuticals in the Dow Jones?
- When was Universe Pharmaceuticals's last earnings report?
- When does Universe Pharmaceuticals report earnings?